September 9, 2021 Comments Off on New patent for Exeltis Usa drug SLYND Posted in: Patent Added Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch – Make …
September 9, 2021 Comments Off on New patent for Biocryst drug ORLADEYO Posted in: Patent Added Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are four patents protecting this drug. This drug has thirty-six…
The post New patent for Biocryst drug ORLADEYO appeared first on Drug…
